Jun 4, 2020, 12:59 by

PRESS RELEASE: Nottingham, UK, June 1, 2020 – Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020. This announcement follows the recent appointment of Jonas Skjødt Møller as Chief Executive Officer of Albumedix and is part of the company’s global growth strategy.

Jun 4, 2020, 12:59 by

N-SIDE announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services to optimize the supply management from protocol design to on-going clinical trials.

Jun 4, 2020, 12:58 by

82% respond that they are implementing elements of virtual trials due to the pandemic

Jun 4, 2020, 12:58 by

Clinical Ink, a global clinical trial technology company, helped expedite the study of a treatment for cytokine storm, the immunological reaction associated with severe cases of COVID-19. Clinical Ink purpose-built and deployed the electronic study environment in just 15 business days.

Jun 4, 2020, 12:58 by

At the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting, Noxopharm, a clinical-stage Australian oncology drug development company, has reported two sets of clinical data relating to the development of NOX66 (Veyonda®) as a treatment for end-stage cancer.

Jun 4, 2020, 12:58 by

Celerion announced today the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America, demonstrating their commitment to further assisting sponsors in meeting the forthcoming USP requirements for compounding investigational drug product in support of early phase clinical trial research.

Jun 3, 2020, 08:20 by User Not Found

Clinical Research News Contributed Commentary | Whether you are a doctor or a patient, the last thing that’s likely on anyone’s mind during a pandemic is data privacy. But just because the economy and our social lives are pretty much on hold because of COVID-19, that doesn’t mean healthcare privacy can afford to be.

May 29, 2020, 07:48 by User Not Found

Clinical Research News | This week saw the clinical research community make a concerted effort to continue treating patients amid the COVID-19 pandemic. And in the meantime, COVID-19 related research is still in progress.

May 28, 2020, 08:49 by User Not Found

Clinical Research News | Researchers are accustomed to having their ideas held up to scientific scrutiny, and testing and building on each other’s work, because that’s what moves the field toward more accurate explanations for problems and probable solutions. But the academic banter has largely devolved into discourses at the extremes during the current pandemic.

May 27, 2020, 10:45 by User Not Found

Clinical Research News | May was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from NHS, Deep Lens, SDL, and more.

May 27, 2020, 10:15 by

Seamless, dynamic solution enables continued interactions between clinical trial patients and investigative sites

May 27, 2020, 10:15 by

Ubiquitome has signed an exclusive agreement for Swiss headquartered DKSH to market and sell its mobile, battery powered COVID-19 tester, Liberty16, in several Asia Pacific countries. The agreement comes on the back of Ubiquitome recently receiving just over half a million dollars in New Zealand Government funding to help with increasing the manufacturing capacity for the Liberty16.

May 27, 2020, 10:14 by

The team at Panasonic Manufacturing UK’s facility in Cardiff have produced 80 prototype breathing devices to assist hospital patients suffering from COVID-19.

May 27, 2020, 10:14 by

ActiGraph, a leading provider of medical-grade wearable physical activity and sleep monitoring solutions for the global scientific community, announced today that it has been acquired by global private equity healthcare specialist ArchiMed.

May 27, 2020, 10:14 by

Rho to Coordinate Study Sponsored by National Institute of Allergy and Infectious Diseases to Determine Rate of COVID-19 Infection in US Children NIH-funded study also aims to identify percentage of children infected with the new coronavirus that develop symptoms of the disease Research Triangle Park, NC – May 21, 2020 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced it is coordinating a new study, called Human Epidemiology and Response to SARS-CoV-2 (HEROS), to help determine the rate of the new coronavirus infection in children and their family members in the U.S. The study also aims to determine what percentage of children infected with SARS-CoV-2, the virus that causes COVID-19, develop symptoms of the disease, as well as whether rates of SARS-CoV-2 infection differ between children who have asthma or other allergic conditions and children who do not. HEROS is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

May 27, 2020, 10:14 by

May 27, 2020, 10:14 by

May 27, 2020, 10:13 by

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

May 27, 2020, 10:12 by

May 27, 2020, 10:12 by

Durham Tech’s clinical trials program utilizes TrialKit, a data collection and study management platform from Crucial Data Solutions